Cargando…
PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
Autores principales: | Dhouib, F., Fourati, N., Zouari, S., Frikha, M., Siala, W., Farhat, L., Mnejja, W., Daoud, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ireland Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153876/ http://dx.doi.org/10.1016/S0167-8140(22)03023-7 |
Ejemplares similares
-
PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
por: Fourati, N., et al.
Publicado: (2021) -
PO-1165 Dosimetric parameters in hypofractionated radiotherapy in NSCLC cohort during SARS-COV-2 pandemia
por: González Ruiz, M.A., et al.
Publicado: (2021) -
PO-1505 Phone call triage for patients admission in a radiotherapy department during COVID 19 pandemic
por: Santo, B., et al.
Publicado: (2021) -
PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak
por: Nardone, V., et al.
Publicado: (2021) -
PO-1058 Estimating the carbon footprint of the radiotherapy pathway and changes in response to COVID-19
por: Cummings, J., et al.
Publicado: (2022)